Start-up & biotech references


Nîmes, France

Fundraising and Business Development

Signed collaboration agreement with a mid-pharma. Ongoing discussions for a more important agreement. Two term-sheet obtained for a fund raising


Seoul, South-Korea

Strategic support & Business Development

Since 2015 BDC worked along QM side. We advised them through all their key development steps. Market preparation, strategy, subsidiary set-up, joint venture set-up, strategic partnerships

Fund raising

Preparation, research and negotiation with VCs. Raise of a successful $24m fundraising (September 2018) from US and Korean investors


Nîmes, France

Business Development

One negotiation closed; more than 30 ongoing negotiations : some advanced, from small to big pharma. For distribution, Joint Venture, collaborations, assets sell… In all parts of the world


Montpellier, France

Support & Business Development

Identification of a strategical partner. Design of the deal structure, negotiation and signature of a long term and key collaboration / development and commercialization deal


Haïfa, Israel

Support & Business Development

Broadening of the company strategy.

From of focus in rare cell isolation for research applications only to cell isolation for cell therapy-based treatments and clinical diagnostics

Mature business & Investors references

Institut Pasteur

Paris, France

IP & Business Development

Review of strategic patent families from the portfolio.
Assets valuation for industrial development potential


London, England

Scouting, due diligences and asset valuation

Identification of investment opportunities for KKR in a therapeutic or a geographic region. Analysis of target with extended due diligences.

Auriga Partners & Kurma Partners

Paris, France

Scouting and Business development

2 separate missions with the same goals:

Identification, contact and negotiation with strategical industrials in order for them to invest and become LPs of new raised funds dedicated to therapeutic domains.




Scouting of scientific projects and companies in Israel based on Servier specification

Contact and meeting

Contact and meeting organization between Servier and identified projects.
Ongoing discussion between Servier and multiple targets



Evaluation of the Spin off potential of a research facility belonging to a big pharma company, in order to continue the activity, after site closure

Technological evaluation and due dilligences